ReviewFrontiers in bioengineering and biotechnology2025
Research advances in nanomaterials with aromatic functional groups for the treatment of inflammatory bowel disease.
Review in Frontiers in bioengineering and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Inflammatory bowel disease (IBD) is a group of chronic, non-specific intestinal inflammatory diseases. The treatment of IBD focuses on alleviating intestinal inflammation. However, traditional drug treatment methods are limited by the side effects of systemic therapy, poor targeting of oral administration, and low bioavailability at the site of inflammation. Fortunately, the application of nanomaterials in the intestine is expected to alleviate these problems. Nanomaterials have unique physicochemical properties and can be used for targeted drug delivery through the mucus layer. Moreover, they can also be engulfed by macrophages through endocytosis, thereby regulating the immune environment of the intestine and potentially altering drug properties. In addition, nanomaterials can be divided into organic nanomaterials and inorganic nanomaterials according to their properties. The functional groups in organic nanomaterials directly determine the characteristics and effects of these materials. Among them, aromatic rings enhance drug stability, improve drug solubility and targeting, and exert anti-inflammatory, antioxidant, and immunomodulatory effects, which are conducive to the innovation of IBD treatment. This paper focuses on the role of aromatic rings, briefly describes the current therapeutic status of organic nanomaterials in inflammatory bowel disease, and discusses the deficiencies of existing research as well as directions for future studies. This paper provides insights into understanding the influence of functional groups on nanomaterials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.